Inhibition of PCSK9 does not improve lipopolysaccharide-induced mortality in mice
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of PCSK9 does not improve lipopolysaccharide-induced mortality in mice
Authors
Keywords
-
Journal
JOURNAL OF LIPID RESEARCH
Volume 58, Issue 8, Pages 1661-1669
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2017-06-10
DOI
10.1194/jlr.m076844
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I
- (2016) Eli M. Roth et al. ATHEROSCLEROSIS
- Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis
- (2016) John H. Boyd et al. Journal of Innate Immunity
- Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis
- (2016) Dhruva J. Dwivedi et al. SHOCK
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- PCSK9 is a critical regulator of the innate immune response and septic shock outcome
- (2014) K. R. Walley et al. Science Translational Medicine
- A Multicenter Randomized Trial of Atorvastatin Therapy in Intensive Care Patients with Severe Sepsis
- (2013) Peter Kruger et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of Statin Therapy on Mortality in Patients With Ventilator-Associated Pneumonia
- (2013) Laurent Papazian JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Severe Sepsis and Septic Shock
- (2013) Derek C. Angus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients
- (2012) David Sullivan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy
- (2012) James M. McKenney et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
- (2012) Evan A Stein et al. LANCET
- Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
- (2012) Evan A. Stein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia
- (2012) Eli M. Roth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crosstalk between reverse cholesterol transport and innate immunity
- (2012) Kathleen M. Azzam et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Plasma PLTP (phospholipid-transfer protein): an emerging role in ‘reverse lipopolysaccharide transport’ and innate immunity
- (2011) Thomas Gautier et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Association Between Statins Given in Hospital and Mortality in Pneumonia Patients
- (2011) Michael B. Rothberg et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Continuation of Statin Therapy in Patients with Presumed Infection
- (2010) Peter S. Kruger et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The acute phase response inhibits reverse cholesterol transport
- (2010) Kenneth R. Feingold et al. JOURNAL OF LIPID RESEARCH
- Statin Therapy Is Associated with Decreased Mortality in Patients with Infection
- (2009) Michael W. Donnino et al. ACADEMIC EMERGENCY MEDICINE
- Genetic and Metabolic Determinants of Plasma PCSK9 Levels
- (2009) Susan G. Lakoski et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inflammation stimulates the expression of PCSK9
- (2008) Kenneth R. Feingold et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Plasma PCSK9 preferentially reduces liver LDL receptors in mice
- (2008) Aldo Grefhorst et al. JOURNAL OF LIPID RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started